BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.
about
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
BCL2 protein signalling determ ...... radiotherapy in rectal cancer.
@en
BCL2 protein signalling determ ...... radiotherapy in rectal cancer.
@nl
type
label
BCL2 protein signalling determ ...... radiotherapy in rectal cancer.
@en
BCL2 protein signalling determ ...... radiotherapy in rectal cancer.
@nl
prefLabel
BCL2 protein signalling determ ...... radiotherapy in rectal cancer.
@en
BCL2 protein signalling determ ...... radiotherapy in rectal cancer.
@nl
P2093
P2860
P50
P1476
BCL2 protein signalling determ ...... oradiotherapy in rectal cancer
@en
P2093
B T Hennessy
C de Chaumont
D A McNamara
L Flanagan
P2860
P2888
P304
P356
10.1007/S00109-014-1221-7
P577
2014-11-13T00:00:00Z